Article
Alphavirus antivirals targeting RNA‐dependent RNA polymerase domain of nsP4 divulged using surface plasmon resonance
14 Feb 2022
Abstract excerpt
Alphaviruses are continuously re‐emerging and pose a global threat to human health and currently no antiviral drug is commercially available for alphaviral infections. Alphavirus non‐structural protein nsP4, which possesses RNA‐dependent RNA polymerase (RdRp) activity, is a potential antiviral target. To date, no antiviral drug is commercially available against alphaviruses. Since RdRp is the key virus‐specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
